Dernière mise à jour :
26/03/2024
Equipes de recherche - University of Michigan, College of Pharmacy   Pdf  
Etats Unis d’Amérique
Université
University of Michigan, College of Pharmacy
Ann Arbor
Bibliographie   Bibliographie   (56)  
1
Stability of i.v. admixture containing metoclopramide, diphenhydramine hydrochloride, and dexamethasone sodium phosphate in 0.9% sodium chloride injection
Kintzel P.E, Zhao T, Wen B, Sun D. ( (polly.kintzel@spectrumhealth)
Am J Health-Syst Pharm - 2014 - ; 71:2061-2065
2
Stability of an extemporaneously prepared thalidomide suspension.
Kraft S, . Johnson C.E, Tyler R.P. (svandeko@med.umich.edu)
Am J Health-Syst Pharm - 2012 - ; 69:56-58.
3
Extended stability of intravenous acetaminophen in syringes and opened vials.
Kwiatkowski J.L, Johnson C.E, Wagner D.S. (debbiew@umich.edu)
Am J Health-Syst Pharm - 2012 - ; 69:1999-2001
4
Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus
Fohl AL, Johnson CE, Cober P. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2011 - ; 68: 69-72.
5
Stability of extemporaneously prepared oxandrolone oral suspensions.
Johnson CE, Cober MP, hawkins KA, Julian JD. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2011 - ; 68:519-521.
6
Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE, Cober MP, Thome T, Rouse E. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2011 - ; 68:420-423.
7
Stability of extemporaneously prepared rifaximin oral suspensions.
Cober MP, Johnson CE, Lee J, Currie K. (mcober@umich.edu)
Am J Health-Syst Pharm - 2010 - ; 67: 287-289.
8
Stability of extemporaneously prepared moxifloxacin oral suspensions
Hutchinson DJ, Johnson CE, Klein KC. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2009 - ; 66: 665-667.
9
Stability of metoprolol tartrate injection 1 mg/ml undiluted and 0.5 mg/ml in 0.9% sodium chloride injection and 5% dextrose injection.
Kraft MD, Johnson CE, Chung C, Julian F. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2008 - ; 65, 7: 636-638.
10
Stability of a flavored formulation of acetylcysteine for oral administration
Siden R, Johnson CE. ()
Am J Health-Syst Pharm - 2008 - ; 65: 558-561.
11
Stability of vecuronium in sterile water for injection stored in polypropylene syringes for 21 days.
Johnson CE, Petrea Cober M. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2007 - ; 64, 22: 2356-2358.
12
Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy.
Cober M.P, Johnson C.E. ()
Am J Health-Syst Pharm - 2007 - ; 64, 23: 2480-2482.
13
Stability of extemporaneously prepared sodium phenylbutyrate oral suspensions
Caruthers RL, Johnson CE. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2007 - ; 64: 1513-1515.
14
Stability of an extemporaneously prepared alcohol-free phenobarbital suspension
Cober MP, Johnson CE. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2007 - ; 64: 644-646.
15
Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.
Johnson CE, Cober MP, Ludwig JL. (cejohn@umich.edu)
Ann Pharmacotherapy - 2007 - ; 41: 1954-1961.
16
Stability of pantoprazole in 0.9% sodium chloride injection in polypropylene syringes.
Johnson CE. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2005 - ; 62: 2410-2412.
17
Stability of anhydrous theophylline in extemporaneously prepared alcohol-free oral suspensions.
Johnson CE, vanDe Koppel S, Myers E. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2005 - ; 62: 2518-2520.
18
Stability of tramadol hydrochloride--acetaminophen (Ultracet) in strawberry syrup and in a sugar-free vehicle
Johnson CE, Wagner DS, DeLoach SL, Cichon-Hensley BK. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2004 - ; 61: 54-57.
19
Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle
Wagner DS, Johnson CE, Cichon-Hensley BK, DeLoach SL. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2003 - ; 60: 1268-1270.
20
Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle
Wagner DS, Johnson CE, Cichon-Hensley BK, DeLoach SL. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2003 - ; 60: 1268-1270
21
Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
VandenBussche HL, Johnson CE, Yun J, Patel SA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2002 - ; 59: 1853-1855.
22
Stability of oral suspensions of ursodiol made from tablets
Johnson CE, Streetman DD. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2002 - ; 59: 361-363.
23
Stability of flucytosine 50 mg/mL in extemporaneous oral liquid formulations
VandenBussche HL, Johnson CE, Yun J, Patel SA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2002 - ; 59: 1853-1855.
24
Stability of norfloxacin in an extemporaneously prepared oral liquid
Johnson CE, Price J, Hession JM. (cejohn@umich.edu)
Am J Health-Syst Pharm - 2001 - ; 58: 577-579.
25
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration.
Johnson CE, VandenBussche HL, Chio CC, Jacobson PA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1999 - ; 56: 164-169.
26
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
Johnson CE, Truong NM. (cejohn@umich.edu)
J Am Pharm Assoc - 1999 - ; 39: 505-509.
27
Stability of levofloxacin in an extemporaneously compounded oral liquid
VandenBussche HL, Johnson CE, Fontana EM, Meram JM. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1999 - ; 56: 2316-2318.
28
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson CE, Wong D, Hoppe HL, Bhatt-Mehta V. ()
Int J Pharm Compound - 1998 - ; 2, 4: 314-317.
29
Stability of torsemide in 5% dextrose injection.
Montgomery PA, Cornish LA, Johnson CE, Fitzpatrick KA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1998 - ; 55: 1042-1043.
31
Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
Johnson C.E, Wong D.V, Hoppe H.L, Bhatt-Mehta V. ()
Int J Pharm Compound - 1998 - ; 2: 314-317.
32
Compatibility of bupivacaine hydrochloride and morphine sulfate.
Johnson CE, Christen C, Perez MM, Ma M. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1997 - ; 54: 61-64.
33
Stability of bumetanide in 5% dextrose injection.
Cornish LA, Montgomery PA, Johnson CE. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1997 - ; 54: 422-423.
34
Stability of tacrolimus in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, West NJ, Foster JA. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1997 - ; 54: 178-180.
35
Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration.
Christen C, Johnson CE, Walters JR. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1996 - ; 53: 170-173.
36
Stability of propofol with parenteral nutrient solutions during simulated Y-site injection.
Bhatt-Mehta V, Paglia RE, Rosen DA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 192-196.
37
Stability of fentanyl citrate and midazolam hydrochloride during simulated intravenous coadministration.
Bhatt-Mehta V, Johnson CE, Leininger N, Agarwal M. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1995 - ; 52: 511-513.
38
Stability of itraconazole in an extemporaneously compounded oral liquid
Jacobson PA, Johnson CE, Walters, JR. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1995 - ; 52: 189-191.
39
Stability of ursodiol in an extemporaneously compounded oral liquid
Johnson CE, Nesbitt J. (cejohn@umich.edu)
Am J Health-Syst Pharm - 1995 - ; 52: 1798-1800.
40
Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
Johnson CE, Jacobson PA, Chan E. ()
Am J Hosp Pharm - 1994 - ; 51: 503-508.
41
Stability of midazolam hydrochloride and morphine sulfate during simulated intravenous coadministration.
Johnson CE, Bhatt-Mehta V, Mancari SC, McKown JA. (cejohn@umich.edu)
Am J Hosp Pharm - 1994 - ; 51: 2812-2815.
42
Stability of isradipine in an extemporaneously compounded oral liquid
MacDonald JL, Johnson CE, Jacobson P. (cejohn@umich.edu)
Am J Hosp Pharm - 1994 - ; 51: 2409-2411.
43
Stability of mesalamine in rectal suspension diluted with distilled water
Henderson LM, Johnson CE, Berardi RR. (cejohn@umich.edu)
Am J Hosp Pharm - 1994 - ; 51: 2955-2957.
44
Stability and compatibility of fluconazole and aminophylline in intravenous admixtures.
Johnson CE, Jacobson PA, Pillen HA, Woycik CL. (cejohn@umich.edu)
Am J Hosp Pharm - 1993 - ; 50: 703-706.
45
Stability of an extemporaneously compounded baclofen oral liquid
Johnson CE, Hart SM. (cejohn@umich.edu)
Am J Hosp Pharm - 1993 - ; 50: 2353-2355.
46
Stability of fluconazole and amino acids in parenteral nutrient solutions.
Couch P, Jacobson P, Johnson CE. (cejohn@umich.edu)
Am J Hosp Pharm - 1992 - ; 49: 1459-1462.
47
Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution
Mason NA, Johnson CE, O'Brien MA. (cejohn@umich.edu)
Am J Hosp Pharm - 1992 - ; 49: 1139 - 1142.
48
Stability of an extemporaneously compounded clonidine hydrochloride oral liquid
Levinson ML, Johnson CE. (cejohn@umich.edu)
Am J Hosp Pharm - 1992 - ; 49: 122-125.
49
Stability of an extemporaneously compounded terbutaline sulfate oral liquid
Horner RK, Johnson CE. (cejohn@umich.edu)
Am J Hosp Pharm - 1991 - ; 48: 293-295.
50
Stability of imipenem and cilastatin sodium in total parenteral nutrient solution.
Zaccardelli DS, Sanders Kromarik C, Wolk R, Khalidi N. ()
JPEN - 1990 - ; 14: 306-309.
51
Compatibility of aminophylline and verapamil in intravenous admixtures.
Johnson CE, Lloyd CW, Mesaros JL, Rubley GJ. (cejohn@umich.edu)
Am J Hosp Pharm - 1989 - ; 46: 97-100.
52
Compatibility of premixed theophylline and verapamil intravenous admixtures.
Johnson CE, Lloyd CW, Aviles AI, Rybarz KL. (cejohn@umich.edu)
Am J Hosp Pharm - 1988 - ; 45: 609-612.
53
Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Michelini TJ, McMahon RE. (cejohn@umich.edu)
Am J Hosp Pharm - 1987 - ; 44: 1620-1624.
54
Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures.
Johnson CE, Cohen IA, Craft DA, Lizer MH. ()
Am J Hosp Pharm - 1986 - ; 43: 1482-1485.
55
Stability of trimethoprim-sulfamethoxazole injection in five infusion fluids.
Deans KW, Lang JR, Smith DE. ()
Am J Hosp Pharm - 1982 - ; 39: 1681-1684.
56
Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate.
Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL. ()
Am J Hosp Pharm - 1981 - ; 38: 1449-1454.

Liste des molécules   Molécules étudiées   (55)  

  Mentions Légales